Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sexual Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05861752
What this trial is testing

Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study

Who this might be right for
Paraphilic DisordersSexual AddictionParasomnia
Region Stockholm 240
Not applicableStudy completedNCT00874185
What this trial is testing

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

Who this might be right for
Erectile Dysfunction
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 720
Not applicableLooking for participantsNCT06912048
What this trial is testing

Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease

Who this might be right for
Autonomic Function
University of Ulm 52
Not applicableStudy completedNCT02887508
What this trial is testing

HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users

Who this might be right for
HIV-1 InfectionRisk Reduction
University of Connecticut 170
Testing effectiveness (Phase 2)Study completedNCT01505114
What this trial is testing

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 594
Testing effectiveness (Phase 2)Study completedNCT06439433
What this trial is testing

ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2Papillomavirus Infectionsp16 Protein
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 119
Not applicableLooking for participantsNCT06444360
What this trial is testing

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

Who this might be right for
HIV
Westat 360
Not applicableUnknownNCT00790959
What this trial is testing

The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda

Who this might be right for
Intimate Partner ViolenceHIV
London School of Hygiene and Tropical Medicine 800
Testing effectiveness (Phase 2)Study completedNCT06033092
What this trial is testing

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Who this might be right for
BRCA MutationPALB2 Gene MutationDuctal Carcinoma in Situ+6 more
European Institute of Oncology 110
Not applicableStudy completedNCT02540304
What this trial is testing

Teen Pregnancy Prevention Replication Study

Who this might be right for
Teen PregnancySexual Risk-taking Behaviors
Abt Associates 7,620
Not applicableLooking for participantsNCT07187947
What this trial is testing

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Who this might be right for
Gender IncongruenceCardiovascular (CV) RiskCardiovascular Disease Risk Factor+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Not applicableStudy completedNCT05093647
What this trial is testing

Sexual Function Changes in High-Risk Pregnancies

Who this might be right for
Sexual Dysfunctions, PsychologicalHigh Risk PregnancySexual Behavior
Saglik Bilimleri Universitesi 200
Not applicableEnded earlyNCT00341887
What this trial is testing

Epidemiological Study of HIV in the South African National Defense Force

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 8,676
Testing effectiveness (Phase 2)Study completedNCT00406484
What this trial is testing

Brief Introductory Therapy for Opioid Dependence

Who this might be right for
Opiate DependenceHIV Infections
Yale University 51
Testing effectiveness (Phase 2)UnknownNCT00227825
What this trial is testing

The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1

Who this might be right for
AdherenceHIV Risk BehaviorsAlcohol & Drug Use+2 more
National Institute on Drug Abuse (NIDA) 60
Not applicableWithdrawnNCT01751100
What this trial is testing

The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies

Who this might be right for
HIV Infections
North Bronx Healthcare Network
Testing effectiveness (Phase 2)Study completedNCT01449565
What this trial is testing

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)

Who this might be right for
Amphetamine-Related Disorders
San Francisco Department of Public Health 100
Not applicableStudy completedNCT05484895
What this trial is testing

Mobile Health Intervention to Increase HIV Testing and Linkage to Care

Who this might be right for
HIV
Emory University 1,800
Not applicableStudy completedNCT00511056
What this trial is testing

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 700
Large-scale testing (Phase 3)Study completedNCT00302822
What this trial is testing

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Who this might be right for
HIV InfectionsAIDS
French National Agency for Research on AIDS and Viral Hepatitis 195
Next Page